معرفی
James Smith is a Professor in the Department of Biological Sciences at Texas A&M University. He joined the department in 2010 and leads the Smith Lab, focusing on antimicrobial discovery and functional characterization. His academic background includes a B.S. in Biology and Secondary Science/Math Teaching (1996, Florida State University), an M.B.A. in Finance/Competitive Strategy (2002, University of Florida), and a Ph.D. in Biochemistry/Microbiology (2002, University of Florida). He completed postdoctoral research at Oragenics Inc. and previously held a faculty position at Mississippi State University.
Smith's research emphasizes novel antimicrobial agents and their roles in understanding cellular/membrane physiology and developing therapeutic strategies. Key areas include biofilm inhibition, probiotic potential of oral microbiota, and antifungal agents like occidiofungin. His work bridges natural product discovery with synthetic chemistry and drug delivery systems, addressing microbial pathogenesis and antibiotic resistance.
Publications highlight advancements in peptide analog engineering, antifungal mechanisms, and sustained drug delivery systems. Collaborative efforts explore clinical applications of antimicrobials in infection models and probiotic reservoirs. His lab continues to investigate enzymatic pathways in antimicrobial synthesis, contributing to both fundamental biology and translational medicine.
No scientific awards are explicitly listed in the provided text. The Smith Lab Webpage provides further details on ongoing projects, funding, and team collaborations.
